Supporting the cost-effectiveness of a thyroid testing algorithm

Clinica Chimica Acta

Volumn 296, Issue 1-2, 2000, Pages 213-215

  López Achigar, Elizabeth ^a   Collazo, Cecilia ^a   Blanco, Raquel ^a   Raymondo, Stella ^a  

^a HOSPITAL MACIEL   (Uruguay)

Author keywords

Algorithm; Cost effectiveness; Thyroid testing

Indexed keywords

LIOTHYRONINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ALGORITHM; COST EFFECTIVENESS ANALYSIS; ENZYME IMMUNOASSAY; PRIORITY JOURNAL; SHORT SURVEY; THYROID FUNCTION TEST; BLOOD; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; LETTER; THYROID DISEASE;

ALGORITHMS; COST-BENEFIT ANALYSIS; HUMANS; THYROID DISEASES; THYROID FUNCTION TESTS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 0343527473     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(00)00192-3     Document Type: Letter

References (14)

1. Wartofsky L. The scope and impact of thyroid disease. Clin Chem. 42:1996;121-124.
2. Weetman A.P. Hypothyroidism: screening and subclinical disease. Br Med J. 314:1997;1175-1178.
3. Fisher D.A. Physiological variations in thyroid hormones: physiological and pathophysiological considerations. Clin Chem. 42:1996;135-139.
4. Feldkamp C.S., Carey J.L. An algorithm approach to thyroid function testing in a managed care setting. 3-year experience. Am J Clin Pathol. 105:1996;11-16.
5. Spencer C.A., Takeuchi M., Kasarosyan M. Current status and performance goals for serum thyrotropin (TSH) assays. Clin Chem. 42:1996;140-145.
6. Ross D.S., Daniels G.H., Gouveia D. The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an out-patient endocrine clinic. J Clin Endocrinol Metab. 71:1990;761-769.
7. Surks M.I., Chopra I.J., Mariash C.N., Nicoloff J.T., Solomon D.H. American Thyroid Association guidelines for use of laboratory tests in thyroid disorders. J Am Med Assoc. 263:1990;1529-1532.
8. Singer P.A., Cooper D.S., Levy E.G., et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. J Am Med Assoc. 273:1995;808-812.
9. Vanderpump M.P.J., Ahlquist J.A.O., Franklyn J.A., Clayton R.N. Consensus statement for good practice and audit measures in the management of hypothyroidism. Br Med J. 313:1996;539-544.
10. Hay I.D., Klee G.G. Linking medical needs and performance goals: clinical and laboratory perspectives on thyroid disease. Clin Chem. 39:1993;1519-1524.
11. Nelson J.C., Wilcox R.B. Analytical performance of free and total thyroxine assays. Clin Chem. 42:1996;146-154.
12. Klee G.G. Clinical usage recommendations and analytic performance goals for total and free triiodothyronine measurements. Clin Chem. 42:1996;155-159.
13. Christofides N.D., Wilkinson E., Stoddart M., Ray D.C., Beckett G.J. Assessment of serum thyroxine binding capacity-dependent biases in free thyroxine assays. Clin Chem. 45:1999;520-525.
14. Stockigt J.R. Guidelines for diagnosis and monitoring of thyroid disease: nonthyroidal illness. Clin Chem. 42:1996;188-192.